The Gaskill Lab Publications

View Gaskill Lab Publications on PubMed

"Deprenyl reduces inflammation during acute SIV infection"
Emmanuel, K, Runner, K, Johnson, HS, Brodnik, Z, Lamberty, B, Morrissey, B, Acharya, A, Byareddy, S, Espana, R, Fox, HS and Gaskill, PJ
iScience, April 2022 doi: 10.1016/j.isci.2022.104207 (2022)

"Functional characterization of the biogenic amine transporters on human macrophages"
Mackie, PM, Gopinath, A, Montas, D, Nielsen, A, Nolan, RA, Runner, K, Matt, SM, McNamee, J, Riklan, J, Adachi, K, Doty, A, Ramirez-Zamora, A, Yan, L, Gaskill, PJ, Streit, WJ, Okun, MS, Khoshbouei, H
JCI Insight, January 2022. doi: 10.1172/jci.insight.151892 (2022)

"Editorial: Advances in Understanding NeuroHIV Associated Changes in Neuroimmune Communication in the Combined Anti-retroviral Therapy (cART) Era"
Gaskill, Peter J., Fields, Jerel Adam, Langford, Dianne T., Stauch, Kelly and Williams, Dionna W.
Frontiers in Neurology, August 2021. doi:10.3389/fneur.2021.763448 (2021)

"Co-receptor signaling in the pathogenesis of neuroHIV"
Nickoloff-Bybel, EA, Festa, LK, Meucci, O and Gaskill, PJ
Retrovirology 18, 24 (2021). doi: 10.1186/s12977-021-00569-x (2021)

"Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV"
Matt, SM, Nickoloff-Babel, EA, Rong, Y, Runner, K, Johnson, H, O'Connor, MH, Haddad, EK, and Gaskill, PJ
Frontiers in Immunology. April 2021. 10.3389/fimmu.2021.663061

"HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System"
Nickoloff-Bybel, EA, Calderon, TA, Gaskill, PJ and Berman JW
J Neuroimmune Pharmacol. June 2020.doi: 10.1007/s11481-020-09927-6 (2019)

"Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages"
Nolan, R.A. , Reeb, K.L, Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., and Gaskill, P.J.
Brain Behav Immun – Health. 2(100030), 1-17. 2020 Feb. doi: 10.1016/j.bbih.2019.100030 (2019)

"Dopamine Increases HIV Entry into Macrophages by increasing Calcium release via an alternative signaling pathway"
Nickoloff, E.A., Mackie, P., Runner, K., Matt, S.M., Khoshbouei, H. and Gaskill P.J.
Brain Behav Immun, 82, 239-252. 2019 Nov. PMCID: PMC6941734 doi: 10.1016/j.bbi.2019.08.191 (2019)

"Where dopamine and immune cells interact: Implications for health and disease"
Matt, SM and Gaskill, Peter J
J Neuroimmune Pharmacol. 2019 May 11. doi:10.1007/s11481-019-09851-4 (2019)

"Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders"
Nolan RA, Muir R, Runner K, Haddad EK, Gaskill PJ
J Neuroimmune Pharmacol. 2019 Mar;14(1):134-156. doi: 10.1007/s11481-018-9825-2. Epub 2018 Dec 5 (2019)

"HIV, Tat and Dopamine Transmission"
Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H
Neurobiol Dis. 2017 Sep;105:51-73. doi: 10.1016/j.nbd.2017.04.015. Epub 2017 Apr 27. Review. PMID: 28457951 (2017)

"Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages"
Gaskill PJ, Yano HH, Kalpana GV, Javitch JA, Berman JW
PLoS ONE, 9(9):e108232. doi:10.1371/journal.pone.0108232 (2014)

"Characterization and Function of the Human Macrophage Dopaminergic System: Implications for CNS Disease and Drug Abuse"
Gaskill PJ, Carvallo L, Eugenin EA, Berman JW
Journal of Neuroinflammation, 2012 Aug 18;9:203. doi: 10.1186/1742-2094-9-203. PMID: 22901451 (2012)

"Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse"
Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, Berman JW
Am J Pathol. 2009 Sep;175(3):1148-59. doi:10.2353/ajpath.2009.081067. Epub 2009 Aug 6. PMID: 19661443 (2009)